RTW Biotech Opportunities Ltd
RTWFF
$1.30
-$0.03-2.26%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 52.24% | 52.24% | 55.50% | 55.50% | 170.03% |
| Total Revenue | 52.24% | 52.24% | 55.50% | 55.50% | 170.03% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 52.24% | 52.24% | 55.50% | 55.50% | 170.03% |
| SG&A Expenses | 48.97% | 48.97% | 8.64% | 8.64% | 14.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 178.88% | 178.88% | 114.90% | 114.90% | 60.16% |
| Total Operating Expenses | 56.87% | 56.87% | 11.52% | 11.52% | 9.20% |
| Operating Income | -62.22% | -62.22% | 20.85% | 20.85% | 35.47% |
| Income Before Tax | 164.15% | 164.15% | -21.30% | -21.30% | 131.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 164.15% | 164.15% | -21.30% | -21.30% | 131.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 164.15% | 164.15% | -21.30% | -21.30% | 131.28% |
| EBIT | -62.22% | -62.22% | 20.85% | 20.85% | 35.47% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 67.06% | 67.06% | -20.63% | -20.63% | 131.29% |
| Normalized Basic EPS | 966.67% | 966.67% | -89.01% | -89.01% | -268.29% |
| EPS Diluted | 67.06% | 67.06% | -20.63% | -20.63% | 131.29% |
| Normalized Diluted EPS | 966.67% | 966.67% | -89.01% | -89.01% | -268.29% |
| Average Basic Shares Outstanding | 58.07% | 58.07% | -0.83% | -0.83% | 0.00% |
| Average Diluted Shares Outstanding | 58.07% | 58.07% | -0.83% | -0.83% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
